RCKTWRocket Pharmaceuticals Inc. Warrant
0.0010USD-54.55%Mkt Cap: —P/E: —3d ago
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-223.12M $
Revenue/Share—
Last Price0.0010 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.00
EPS (TTM)—
EPS (Forward)—
52W Range
0.00052% of range0.0220
52W High0.0220 USD
52W Low0.0005 USD
Profitability
Gross Margin—
Oper. Margin—
EBITDA Margin—
Profit Margin—
ROE-80.49%
ROA-67.52%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-190.01M $
CapEx (TTM)440.00K $
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.09
Current Ratio—
Quick Ratio—
Book Value/Sh2.181 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float—
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta—
S&P 52W Chg—
Avg Vol (30d)74.67K
Avg Vol (10d)—
Technical Indicators
RSI (14)36.4
MACD-0.0029
MACD Signal-0.0033
MACD Hist.+0.0005
BB Upper0.0041 USD
BB Middle0.0023 USD
BB Lower0.0006 USD
BB Width151.26%
ATR (14)0.0017 USD
Vol Ratio (20d)0.69x